Categories
Connect with us on LinkedIn
Getting Started with DCT in 2022
Castor advisor Craig Lipset, suggests that you consider DCT technology as three separate tiers. Learn more about these...
How to Incorporate Remote Technology in Your Next Medical Device Trial
Researchers are looking to incorporate remote technologies into medical device trials for a wide range of device classifications....
Overview of EU Medical Device Regulations
Medical device regulations in the EU have recently undergone a major overhaul. Learn the key tenets of MDR...
Castor Appoints Digital Leader Milind Kamkolkar to Board of Directors
Industry veteran Milind Kamkolkar joins Castor’s Board of Directors to advance mission of democratizing clinical research by maximizing...
How Medical Device Trials Can Benefit From Decentralized Methods
In this whitepaper, we will look at how EDC, eConsent, ePRO, and APIs enable researchers to easily conduct...
Castor is accelerating global medical device research with decentralized clinical trials platform
Castor’s DCT platform helping medical device trials achieve compliance with patient-focused technology Driving innovation for medical device clinical...
Capturing and Managing Data in DTx Trials
Download this whitepaper to gain a comprehensive overview of DTx, its regulatory landscape, and routes to commercialization.
Digital Therapeutic Cybersecurity: Know Your Data Flow
A robust digital therapeutics cybersecurity system is integral to protecting users’ sensitive information helps meet regulatory requirements and...
How Decentralized Trials Can Support Meaningful Diversity
The Castor team is thrilled to see an increasing emphasis on diversity of race, gender, and even geography...
It’s a Matter of Choice: Hybrid eConsent for On-Site or Remote Patient Enrollment
Thought leaders from Castor and Lightship discuss opportunities that will help researchers develop a more successful overall strategy...
eBook: eConsent
Download this eBook to gain a comprehensive overview of eConsent, how it satisfies global regulatory requirements and key...
3 Ways eConsent Tackles the Challenges of Modern Clinical Trials
Although eConsent struggled to gain momentum and wider acceptance pre-pandemic, it's now a major part of clinical research....
Digital Therapeutic Cybersecurity: Keeping Participant Data Safe
DTx represent an emerging field of software-driven, evidence-based products intended to “prevent, manage, or treat a medical disease...
Using Remote Image Capture eCOA for Hybrid Dermatology Trials
Learn how a remote-first approach to dermatology trials can streamline enrollment, increase patient retention, and ensure data quality.
Trialbee and Castor Partner to Democratize Access and Simplify Enrollment to Clinical Trials Globally
Trialbee, the leading enrollment performance company, and Castor, a leading provider of decentralized and hybrid clinical trial solutions,...
How Medical Device Trials Can Benefit from Decentralized Methods
At Castor, we hope to see DCT extend into all trials as we work alongside researchers in the...
Castor Expands Executive Leadership Team to Scale Clinical Trial Platform Technology
announced two executive appointments to accelerate the company’s growth and impact on the industry. Kimberly Tableman as Chief...
The evolution of eConsent
Since it was first instituted in the 1960s, written consent to participate in research studies has undergone very...
Connect with us on LinkedIn
